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Background: Surgical site infection remains a complication of spine surgery despite routine use of prophylactic anti-
biotics. Retrospective clinical studies of intrawound vancomycin use have documented a decreased prevalence of surgical
site infection after spine surgery. The purpose of the present study was to assess the efficacy of intrawound vancomycin
powder in terms of eradicating a known bacterial surgical site contamination in a rabbit spine surgery model.
Methods: TwentyNewZealandWhite rabbits underwent lumbar partial laminectomy andwire implantation. The surgical sites
were inoculated, prior to closure, by injecting 100 mL of cefazolin-sensitive and vancomycin-sensitive Staphylococcus aureus
(S. aureus) (1 · 108 colony-forming units [CFU]/mL) into the wound. Preoperative cefazolin was administered to all rabbits, and
vancomycin powder (100 mg) was placed into the wound of ten rabbits prior to closure. The rabbits were killed on postop-
erative day four, and tissue andwire samples were obtained for bacteriologic assessment. An independent samples t test was
used to assess mean group differences, and a Fisher exact test was used to assess differences in categorical variables.
Results: The vancomycin-treated and the control rabbitswere similar inweight (mean [and standard deviation], 4.1± 0.5 kg and
4.0± 0.4 kg, respectively; p= 0.60) and sex distribution and had similar durations of surgery (21.7± 7.7minutes and16.9± 6.7
minutes; p = 0.15). The bacterial cultures of the surgical site tissues were negative for all ten vancomycin-treated rabbits and
positive for all ten control rabbits (p < 0.0001). Bacterial growth occurred in thirty-nine of forty samples from the control group
but in zero of forty samples from the vancomycin group (p < 0.0001). All blood and liver samples were sterile. No rabbit had
evidence of sepsis or vancomycin toxicity. Gross examination of the surgical sites showed no differences between the groups.
Conclusions: In a rabbit spine-infection model, intrawound vancomycin powder in combination with preoperative ce-
fazolin eliminated S. aureus surgical site contamination. All rabbits that weremanaged with only prophylactic cefazolin had
persistent S. aureus contamination.
Clinical Relevance: This animal study supports the findings in prior clinical reports that intrawound vancomycin powder
helps reduce the risk of surgical site infections.
S
urgical site infection is a known complication of spine
surgery. The prevalence of postoperative spine infec-
tion varies with the type of surgery, ranging from 1%
to 3% after anterior cervical and lumbar decompression
surgery to approximately 10% to 15% after fusion to treat spine
trauma or neuromuscular scoliosis1-12. The risk of devel-
oping a surgical site infection is multifactorial. Authors of
prior studies have described both patient risk factors, such
as obesity, diabetes, and an immunocompromised state, and
operative risk factors, such as multilevel surgery, use of
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instrumentation, revision surgery, and large intraoperative
blood loss13-15.
The use of preoperative prophylactic intravenous antibi-
otics reduces the rate of surgical site infections and has become
routine practice16-20. Unfortunately, surgical site infection can still
develop. Local administration of antibiotics is an alternative treat-
ment strategy to prevent surgical site infection. The advantages of
locally administered antibiotics are that they are introduced di-
rectly into the surgical site, eliminate the need for diffusion into
the wound that is associated with systemic antibiotics, and offer
the potential to obtain a high antibiotic concentration within the
surgical site. At high concentration, an antibiotic may become
bactericidal even to resistant bacteria21. Local antibiotic admin-
istration has been studied with different delivery methods and
antibiotics, with positive results22-26.
The use of intrawound vancomycin powder in adult
spine surgery has been described in several retrospective clin-
ical series27-31. In these series, the authors found a significantly
lower postoperative infection rate with use of intrawound
vancomycin powder for diverse surgical populations, including
those treated for adult degenerative disease27,29, deformity30, or
spine trauma28 and those treated with cervical spine surgery31.
The purpose of the current study was to assess the efficacy of
intrawound vancomycin powder with regard to reducing sur-
gical site contamination in a rabbit spine-infection model. Our
hypothesis was that rabbits managed with intrawound vanco-
mycin powder would have less bacterial colonization and tissue
infection as demonstrated by microbiological testing.
Materials and Methods
Bacterial Preparation
Staphylococcus aureus (S. aureus) was utilized for the surgical site infectionsbecause it is the most common bacterial cause of postoperative infec-
tions
3,31,32
. The S. aureus (American Type Culture Collection [ATCC] number
25923) isolate used for inoculation was obtained from a repository maintained
at our hospital clinical microbiology laboratory. This is a methicillin-sensitive
strain that has been used in prior animal studies on intrawound gentamicin
application
24,25
. This bacterial strain was confirmed to be sensitive to both ce-
fazolin and vancomycin. The identity of this isolate was confirmed on the basis
of morphologic characteristics and biochemical analysis (VITEK 2; bioMe´rieux,
Durham, North Carolina). Organisms used for this experiment were grown on
5% sheep blood agar culture (Northeast Laboratory Services, Waterville,
Maine) for twenty-four hours at 37C. Bacteria were collected with use of
a sterile swab and then were suspended in sterile phosphate-buffered saline
solution to the desired concentration. Colony counts and the presence of the
organisms in the pure culture were verified by plating serial dilutions of the
bacterial suspension on 5% sheep blood agar. In an initial phase, New Zealand
White rabbits were challenged with varying concentrations of S. aureus to
reliably create surgical site contamination. On the basis of this preliminary
work and a prior report
23
, a 1 · 108 colony forming units [CFU]/mL con-
centration of S. aureus was used for bacterial surgical site inoculation because
it reliably produced a contaminated surgical site.
Study Design
The study protocol was approved by our Institutional Biosafety Committee
and Institutional Animal Care and Use Committee. The study design was based
on a prior rabbit spine-surgery infection model that reliably mimics human
posterior spine surgery
33
. Twenty New ZealandWhite rabbits were divided into
two groups of ten rabbits each. Ten control rabbits received one preoperative
dose of cefazolin, and ten experimental rabbits received preoperative cefazolin
as well as intrawound vancomycin powder. The preoperative 30-mg/kg cefaz-
olin dose was based on a prior prophylactic antibiotic rabbit spine-infection
study
34
. Postoperative cefazolin was not administered because a prior study had
shown that a single preoperative cefazolin dose was as effective as a combina-
tion of preoperative and postoperative cefazolin in preventing surgical site




In the presurgical holding area, the rabbits were anesthetized with a ketamine
and xylazine cocktail (20 mg/kg and 2.5 mg/kg, respectively, given intra-
muscularly) and maintained with 3% to 5% isoflurane gas. The rabbits were
intubated, and the posterior aspect of the thoracic and lumbar spine was
shaved. The preoperative cefazolin was administered fifteen minutes before
the skin incision was made. The posterior thoracic and lumbar regions of the
trunk were prepared with a Betadine (povidone-iodine) scrub, an alcohol
swab, and Betadine paint, and the surgical site was sterilely draped. A 1.5-cm
incision centered on approximately L3 was made, and sharp dissection
through the subcutaneous tissue and fascia down to the lumbar spinous
process was performed. Retractors were placed to reflect the superficial tissue
and expose the spinous process, and a rongeur was used to remove the entire
spinous process and surrounding musculature, creating a defect mimicking a
partial laminectomy. The ligamentum flavum and the dura were not exposed.
A 5-mm Kirschner wire was implanted into the transverse process to mimic
posterior instrumentation. A sterile pipette was used to inoculate the wound
with 100 mL of 1 · 108 CFU/mL of S. aureus. The experimental rabbits were
treated with 100 mg of vancomycin powder placed directly within the wound
prior to closure. A 100-mg vancomycin dose in a 4-kg rabbit is equivalent to a
2-g dose in an 80-kg human adult, which has been previously shown to be
safe and effective in humans
27
. The deep muscle and the fascia were closed
with PROLENE (polypropylene) sutures in order to contain the vancomycin
powder within the surgical site, and the skin was closed with subcuticular
PROLENE sutures and DERMABOND adhesive (Ethicon, Somerville, New
Jersey). Postoperative analgesia included Buprenex (buprenorphine hy-
drochloride; 0.02 mg/kg subcutaneously) and a 25-mg/hr fentanyl patch.
The animals were monitored daily for signs of pain, infection, and other
complications.
TABLE I Rabbit and Surgical Descriptive Characteristics
Vancomycin Rabbits Control Rabbits P Value
Sex (M:F) 6:4 2:8 0.17
Weight*(kg) 4.1 ± 0.5 4.0 ± 0.4 0.60
Duration of surgery* (min) 21.7 ± 7.7 16.9 ± 6.7 0.15
Initial S. aureus concentration (CFU) 1 · 108 1 · 108
*The values are given as the mean and standard deviation.
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Bacterial Evaluation
Four days postoperatively, the rabbits were resedated for blood collection and
were then killed via an intravenous pentobarbital overdose. The surgical inci-
sion was prepared with a Betadine scrub, the surgical site was sterilely draped,
and the skin and fascial incisions were reopened under sterile conditions in
order to expose the laminectomy defect. Sterile instruments were used to
harvest wound tissue, including the fascia, muscle, lamina, and transverse
process, and the surgical wire and the tissues were placed into sterile test tubes.
A 2 · 2-cm liver biopsy specimen was also collected under sterile conditions.
The collected specimens were divided for bacteriologic analysis. The
tissues used for bacteriologic culture were individually weighed and then placed
with a specified volume of sterile saline solution in a sterile tissue grinder
(Fisherbrand Closed Ultra Tissue Grinder System; Thermo Fisher Scientific,
Houston, Texas). Samples were ground with use of this system to achieve
disruption of tissues and the release of bacterial colonies, resulting in a cloudy
supernatant. A specified volume of this supernatant consisting of the ground
tissue and saline solution was plated on 5% sheep blood agar and incubated for
a minimum of twenty-four hours at 37C. The retrieved implanted wire was
weighed and was placed in a known volume of sterile saline solution. The wire
and saline solution were sonicated (Ultrasonic FS-14; Fisher Scientific, Houston,
Texas) at room temperature for ten minutes to facilitate release of bacterial
colonies from the wire. A specified aliquot of this sonicated saline solution was
plated on 5% sheep blood agar and incubated for a minimum of twenty-four
hours at 37C. The blood collected just prior to killing the rabbits was placed in
a blood culture tube (Bac T/ALERT FA; bioMe´rieux), according to the man-
ufacturer’s recommendations, and was incubated at 37C for seven days, after
which it was plated on 5% sheep blood agar and then incubated at 37C for a
minimum of twenty-four hours.
After the incubation period, the colonies grown were counted and were
identified on the basis of morphologic characteristics and biochemical analysis
(VITEK 2; bioMe´rieux). Antibiotic sensitivity tests were performed on the
bacteria isolated from each animal.
Statistical Analysis
An independent samples t test was used to assess mean group differences and a
Fisher exact test was used to assess differences in categorical variables (SPSS;
IBM, Armonk, New York). Significance was set at p < 0.05.
Source of Funding
No external funding was received to support the present study.
Results
The vancomycin-treated and control rabbits were similarin weight (vancomycin: 4.1 ± 0.5 kg [mean and standard
deviation], control: 4.0 ± 0.4 kg; p = 0.6) and sex distribu-
tion (six vancomycin-treated male rabbits, two control male
rabbits; p = 0.17), and had similar durations of surgery
(vancomycin: 21.7 ± 7.7 minutes, control: 16.9 ± 6.7 minutes;
p = 0.15) (Table I). There were no postoperative wound
complications, deaths, or evidence of systemic illness. The
surgical wounds of the ten vancomycin-treated rabbits did
not display any evidence of local infection, and there were
no apparent systemic effects from the vancomycin adminis-
tration. One control rabbit had erythema and a small wound
dehiscence, whereas the other nine control rabbits had
subjectively unremarkable incisions. No rabbit had wound
drainage.
TABLE II Difference in Rates of Positive Cultures Between Vancomycin-Treated and Control Rabbits on Final Bacteriologic Culture Analysis
Fascia Muscle Bone Wire Blood Liver
No. positive cultures/total no.
Vancomycin-treated 0/10 0/10 0/10 0/10 0/10 0/10
Control 10/10 10/10 10/10 9/10 0/10 0/10
P value <0.0001 <0.0001 <0.0001 <0.0001 1 1
TABLE III Results of Final Bacteriologic Culture Analysis of Control Rabbit Infections
Bacterial Colony Count (CFU/g)
Control Rabbit Fascia Muscle Bone Wire
1 6.42 · 102 * * 4.75 · 103
2 * * * 2.06 · 105
3 1.79 · 104 9.92 · 104 * 2.46 · 106
4 2.71 · 104 * 8.56 · 104 1.10 · 105
5 * * 1.48 · 104 3.0 · 104
6 1.84 · 105 * * 6.63 · 104
7 * * 3.45 · 104 5.0 · 103
8 7.33 · 104 * 9.74 · 104 Negative culture
9 4.08 · 104 * 3.80 · 104 8.33 · 103
10 * * * 2.44 · 104
*Too many bacteria to quantify.
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Bacteriologic Culture
Bacteriologic cultures confirmed that all surgical sites were
inoculated with 1 · 108 CFU/mL of S. aureus. All ten control
rabbits had positive bacteriologic wound cultures on postop-
erative day four, whereas none of the ten vancomycin-treated
rabbits had a positive culture. This difference was significant
(p < 0.0001) (Table II). None of the forty samples (tissue or
wire) from the vancomycin-treated rabbits and thirty-nine of the
forty from the control rabbits had bacterial growth (p < 0.0001)
(Table II). For the control rabbits, bacteriologic colony counts
typically ranged from 103 to 105 CFU/g tissue (Table III). In some
tissues, bacterial colonies were too numerous to count (Table III),
which precluded a determination of recovered bacterial concen-
trations. All organisms grown on culture were S. aureus. There
were no polymicrobial infections. The S. aureus grown on
culture was sensitive to cefazolin and vancomycin. None of the
blood or liver samples in either rabbit group showed bacterial
growth.
Discussion
Using a rabbit spine surgical-wound-infection model, wefound that intrawound vancomycin was substantially more
effective at eliminating surgical site contamination than intra-
venous cefazolin alone. In fact, all surgical sites in the vancomycin
group were sterile, whereas all control-rabbit wounds had ev-
idence of persistent contamination on bacteriologic culture.
Systemically administered antibiotics, such as cefazolin,
rely on diffusion into the surgical wound for their treatment
effect against surgical site infection. The concentration of
these antibiotics within the wound is expected to be low. In
contrast, locally administered antibiotics achieve high con-
centrations at the surgical site, with safe systemic concentra-
tions22,36. Locally administered vancomycin can reach levels
twenty times the toxic serum levels while maintaining a safe
systemic concentration, which is likely due in part to the large
molecule size of vancomycin preventing systemic absorption36.
The ability to achieve increased antibiotic concentrations with
intrawound administration is important because bacteria resis-
tant to a particular antibiotic at low concentration may be sus-
ceptible to the antibiotic at a higher concentration21. In addition,
the spread of bacterial resistance may be less with local delivery
because fewer bacteria are exposed to the antibiotic than with
systemic administration. Our data suggest that the intrawound
vancomycin concentration was sufficiently high to overcome a
known S. aureus wound contamination in the experimental
rabbits.
Our results for the elimination of acute surgical site
bacterial contamination with use of a locally administered
antibiotic are similar to those in a study by Stall et al., who
reported a significantly reduced surgical site infection rate in
rabbits managed with local gentamicin microspheres12. The
two studies were similar in design and used the same S. aureus
strain in a New Zealand White rabbit spine-infection model.
However, 38% of the surgical sites in the study by Stall et al. had
persistent positive bacteriologic cultures with gentamicin micro-
spheres. The possible explanations for this discrepancy are that
the microspheres acted as both an antibiotic-delivery platform
and a foreign body for bacterial adhesion. In addition, local
antibiotic-delivery systems were utilized to allow for a more
gradual and sustained elution of the antibiotic over time. The
consequence may have been that the initial local antibiotic
concentration did not reach a level high enough to overwhelm
the bacterial load and allowed some bacteria to survive.
Using a rat infection model, Yarboro et al. found a sig-
nificantly reduced infection rate for surgical sites treated with
locally injected aqueous gentamicin compared with those
treated with locally administered calcium-sulfate flakes with
gentamicin or treated with systemic gentamicin24. They pro-
posed that this difference might have arisen because the cal-
cium sulfate acted as a harbor for bacterial adherence. In addition,
gentamicin peak concentrations may have differed between lo-
cally administered gentamicin and gentamicin-laden calcium
sulfate. In a follow-up study, Cavanaugh et al. reported that the
use of a combination of systemic cefazolin and local gentamicin
was more effective at decreasing surgical site bacterial count than
the use of systemic cefazolin or local gentamicin alone25. Our
results support this finding, as the use of systemic cefazolin and
local vancomycin was superior to the use of systemic cefazolin
alone. A combination of systemic and local antibiotics may
have a synergistic effect on the reduction of a surgical bacterial
load.
The current standard of care for preoperative antibiotic
prophylaxis for spine surgery is the use of an intravenous
cephalosporin, most commonly 1 to 2 g of cefazolin (2 g for
patients weighing >80 kg)37. We chose to use 30 mg/kg of ce-
fazolin in the present study because this dose had been used for
prior rabbit spine-infection studies and was recommended by
our veterinarian (M.T.)34,35. Clinical reports on intrawound
vancomycin powder use for spinal surgery have described the
application of 1 to 2 g, and in the largest clinical series of which
we are aware (911 patients) 2 g of vancomycin powder was
placed subfascially without systemic toxicity27. On the basis of
an average weight of 4 kg for the New Zealand White rabbits
and surgical site area of 3.38 cm3, application of 100 mg of
intrawound vancomycin powder to the rabbit would be equiv-
alent to 2 g of vancomycin for an 80-kg human patient.
There is concern that high concentrations of vancomycin
powder applied locally to a wound may be cytotoxic to osteo-
blasts. Authors of prior studies have reported that a vancomycin
concentration below 1000 mg/mL had little or no effect on os-
teoblast growth, whereas 10,000mg/mL caused cell death38,39. We
placed 100 mg of vancomycin into a surgical site of 3.38 cm3, for
a local vancomycin concentration of approximately 30 mg/mL.
This vancomycin concentration falls well below the critical
threshold for reduced cell activity and death. It is important to
recognize that, in these in vitro studies, direct contact between
the high-concentration vancomycin and the osteoblast cells
was maintained for twenty-four to seventy-two hours. In con-
trast, a high concentration of local vancomycin in a surgical site
is transient, and is often significantly reduced by twenty-four
hours post-administration to below-cytotoxic concentration
levels27,40.
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Other investigators also have used the methicillin-
sensitive S. aureus strain that we utilized in the current
study23-25. This bacterial strain has caused the death of un-
treated control rats, as reported by Yarboro et al.24, but not of
treated rats or New Zealand White rabbits23,25. This difference
may be associated with the differing immune systems of the
different species and the ability of each species to combat local
and systemic infections. In the current investigation, there
was no associated mortality in either treatment group. In
addition, blood and liver samples were sterile, indicating
that a systemic infection did not occur. As we did not include
a control group that was not managed with cefazolin or
vancomycin, we do not know whether untreated rabbits
would have a higher bacterial inoculation or mortality rate.
Also, caution should be used when extrapolating these results
to infections caused by organisms other than methicillin-
sensitive S. aureus.
We acknowledge several study limitations. First, we used
a strain of methicillin-sensitive S. aureus. This bacterium was
chosen because, in prior animal experiments, it had been
shown to reliably reproduce in vivo infections. Our results may
not extrapolate to other bacteria, which will be a focus of future
work, but, to our knowledge, these results provide the first
basic-science data that support prior clinical reports of di-
minished rates of surgical site infections with use of intra-
wound vancomycin. Second, we chose the fourth postoperative
day end point to evaluate for tissue bacterial infection because
the local tissue concentration of vancomycin drops steadily
after the third postoperative day27. Thus, we are unable to offer
evidence regarding the effectiveness of local vancomycin in
preventing chronic, delayed infections. The fact that no bac-
teria were found in the vancomycin group supports the notion
that the contaminant had been eliminated and that any future,
deep infection would require hematogenous seeding. The
primary aim of the present study was to assess whether a local
vancomycin concentration could substantially eliminate a
known bacterial wound contaminant, and this was shown by
our results. Although our study was adequately powered to
achieve our primary aim, it may have been underpowered to
accurately assess the risk of complications related to high-
concentration, local vancomycin. The use of a 100-mg vanco-
mycin local dose was chosen to mimic that used in the largest
clinical series of which we aware—that of Sweet et al., who used
2 g of vancomycin powder in 911 patients without reported
systemic toxicity27. None of the vancomycin-treated rabbits had
any apparent clinical vancomycin toxicity effects within the
four postoperative days, but we were unable to reliably measure
serum vancomycin levels in these rabbits.
In conclusion, the use of intrawound vancomycin
powder eliminated S. aureus bacterial contamination in rabbit
spine surgical wounds, whereas the use of systemic cefazolin
alone did not. A high concentration of vancomycin is pro-
duced at the surgical site with no apparent systemic toxicity
from this local concentration. The present study corroborates
the findings in prior clinical series that demonstrated the
effectiveness of intrawound vancomycin powder in spinal
surgery. n
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